<DOC>
	<DOCNO>NCT02139618</DOCNO>
	<brief_summary>Treatment actinic damage include multiple procedure date limit scientific evidence support preferential use one therapy accord efficacy , safety pain tolerance patient . This study aim assess efficacy methyl aminolevulinate + daylight v placebo + daylight treat facial photodamage</brief_summary>
	<brief_title>Efficacy Methyl Aminolevulinate + Daylight Patients With Facial Photodamage</brief_title>
	<detailed_description />
	<mesh_term>Facies</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<mesh_term>Methyl 5-aminolevulinate</mesh_term>
	<criteria>Adults symmetric facial photodamage grade 2 3 ( DoverÂ´s scale ) Patients willing participate Signed informed consent Pregnant nursing female Subjects photosensitize disorder Any active infectious skin disorder History herpes simplex face Subjects le 6 month previous rejuvenation interfere treatment History systemic isotretinoin last year Subjects require concurrent treatment would interfere study objective and/or assessment History hypersensitivity reaction Activities high sun exposure 48 hour treatment Clinical suspicion systemic local malignancy</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Randomized-controlled-trial</keyword>
	<keyword>Methyl-Aminolevulinate</keyword>
	<keyword>Daylight</keyword>
	<keyword>Photodynamic-therapy</keyword>
</DOC>